Cover Image

Adalimumab: A key element in the treatment strategy for immune-mediated inflammatory diseases: A review

Adalimumab is a biological drug effectively used in the treatment of several immune-mediated inflammatory diseases, including ankylosing spondylitis, juvenile idiopathic arthritis, and psoriasis. This study analyzed the therapeutic and economic benefits of adalimumab. Patients with ankylosing spondy...

Full description

Saved in:

Bibliographic Details
Main Authors:	Mariam A. Gilavian (Author), Daria V. Trunova (Author), Anastasia V. Ustinova (Author), Anna M. Sukhanova (Author)
Format:	Book
Published:	ZAO "Consilium Medicum", 2024-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Immune-mediated inflammatory diseases (IMIDs) in children: key research questions and some answers
by: Tilmann Kallinich, et al.
Published: (2024)

Adalimumab in Pediatric Inflammatory Bowel Disease
by: So Yoon Choi, et al.
Published: (2022)

Inflammatory and Immune-Mediated Cutaneous Diseases
by: Juarez A. S. Quaresma, et al.
Published: (2017)

PPARs as Key Mediators of Metabolic and Inflammatory Regulation
Published: (2022)

Extending the in vivo Half-Life of Adalimumab Fab via Sortase A-Mediated Conjugation of Adalimumab Fab with Modified Fatty Acids
by: Qing-Bin Zhang, et al.
Published: (2020)

Acneiform eruptions and inflammatory striae as probable reactions to adalimumab
by: Shilpa Garg, et al.
Published: (2018)

Real-World Evidence of Clinical Outcomes of the Use of the Adalimumab Biosimilar SB5 in Rheumatic and Gastrointestinal Immune-Mediated Inflammatory Diseases: 12-Month Data from the PERFUSE Study
by: Bruno Fautrel, et al.
Published: (2024)

Biomechanical indicators of key elements of sports equipment gymnastic exercises
by: V.A. Potop, et al.
Published: (2013)

Biomechanical indicators of key elements of sports equipment gymnastic exercises
by: Potop V.A, et al.
Published: (2013)

Key Elements of Green Chemistry
by: Lucia, Lucian
Published: (2018)

Teaching and Learning Centre: Analysis of Key Elements
by: Antonella Lotti, et al.
Published: (2022)

Adalimumab
by: Nilgun Atakan
Published: (2022)

Tea Polyphenols Regulate Key Mediators on Inflammatory Cardiovascular Diseases
by: Jun-ichi Suzuki, et al.
Published: (2009)

Facial Hyperpigmentation: A Rare Side Effect of Adalimumab
by: Malek Mrad MD, et al.
Published: (2024)

Adherence to treatment with adalimumab, golimumab and ustekinumab in patients with inflammatory bowel disease
by: María Calvo-Arbeloa, et al.
Published: (2020)

Pregnancy in patients with immune-mediated inflammatory diseases
by: Verónica Sánchez-García, et al.
Published: (2022)

Demonstration of Physicochemical and Functional Similarity of Biosimilar Adalimumab-aqvh to Adalimumab
by: Yijia Jiang, et al.
Published: (2023)

ADALIMUMAB USAGE CASE IN A PATIENT WITH JUVENILE OLIGOARTHRITIS AND UVEITIS
by: L. A. Balykova, et al.
Published: (2013)

Adalimumab induced psoriasis during the treatment of inflammatory bowel disease - case report
by: Edyta Lelonek, et al.
Published: (2015)

Successful treatment of disseminated granuloma annulare with adalimumab
by: Denis V. Zaslavsky, et al.
Published: (2023)

Immune-mediated mechanisms of the inflammatory response in women with combined infections of the lower genital tract
by: G. B. Dikke, et al.
Published: (2021)

Nursing leadership: Key element of professional development
by: Xiaoying Jiang
Published: (2024)

EFFICACY OF ADALIMUMAB IN A PATIENT WITH JUVENILE IDIOPATHIC ARTHRITIS AND UVEITIS
by: L. A. Galstyan, et al.
Published: (2012)

Art and informatics: key elements for a new school "grammar"
by: Andrea de Farias Castro
Published: (2015)

Innate Immune Cells and Inflammatory Mediators in Mucosal Pathologies
Published: (2020)

Heat Stress-Mediated Activation of Immune-Inflammatory Pathways
by: Juan M. Cantet, et al.
Published: (2021)

Heme Cytotoxicity And The Pathogenesis of Immune Mediated Inflammatory Diseases.
by: Rasmus eLarsen, et al.
Published: (2012)

ADALIMUMAB IN TREATMENT OF SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
by: R. V. Denisova, et al.
Published: (2013)

Gaseous Mediators as a Key Molecular Targets for the Development of Gastrointestinal-Safe Anti-Inflammatory Pharmacology
by: Aleksandra Danielak, et al.
Published: (2021)

Can the TLR-4-Mediated Signaling Pathway Be "A Key Inflammatory Promoter for Sporadic TAA"?
by: Giovanni Ruvolo, et al.
Published: (2014)

Addition of cyclosporine to adalimumab improved psoriasis and adalimumab-induced injection site reaction
by: Satoshi Nakamizo, et al.
Published: (2014)

Evaluation of the Predictive Performance of Population Pharmacokinetic Models of Adalimumab in Patients with Inflammatory Bowel Disease
by: Silvia Marquez-Megias, et al.
Published: (2021)

Efficacy of adalimumab in moderate to severe hidradenitis suppurativa: Real life data
by: Aikaterini Kyriakou, et al.
Published: (2018)

PROSPECT IN TREATMENT OF JUVENILE RHEUMATOID ARTHRITIS WITH ADALIMUMAB
by: E.I. Alexeeva, et al.
Published: (2008)

PROSPECT IN TREATMENT OF JUVENILE RHEUMATOID ARTHRITIS WITH ADALIMUMAB
by: E.I. Alexeeva, et al.
Published: (2008)

Under the Umbrella of Clinical Pharmacology: Inflammatory Bowel Disease, Infliximab and Adalimumab, and a Bridge to an Era of Biosimilars
by: Zvonimir Petric, et al.
Published: (2022)

The directive function, key element for the development of educational institutions
by: Luis Batanaz Palomares
Published: (2006)

Diffuse large B-cell lymphoma that develops after adalimumab using adalimumab in a patient with psoriasis
by: Esra Yıldırım Bay, et al.
Published: (2021)

Biomechanical characterization dismount from balance beam on the basis of the analysis of key elements of sports equipment
by: V.A. Potop, et al.
Published: (2013)

Splenic tuberculosis in a patient with ankylosing spondylitis treated with adalimumab
by: M. Fernandes, et al.
Published: (2011)